Humanized anti-AF-20 monoclonal antibody

Details for Australian Patent Application No. 2005210695 (hide)

Owner Nymox Corporation

Inventors Averback, Paul A.; Gemmell, Jack

Agent FB Rice

Pub. Number AU-A-2005210695

PCT Pub. Number WO2005/075647

Priority 60/541,944 06.02.04 US

Filing date 4 February 2005

Wipo publication date 18 August 2005

International Classifications

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/075647 Priority application(s): WO2005/075647

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210720-Actuating device for self cooling packaging

2005210692-Down hole fluid heating apparatus and method